摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2-Dimethylbenzo[d][1,3]dioxole-4-carbaldehyde | 134817-17-7

中文名称
——
中文别名
——
英文名称
2,2-Dimethylbenzo[d][1,3]dioxole-4-carbaldehyde
英文别名
2,2-dimethyl-1,3-benzodioxole-4-carbaldehyde
2,2-Dimethylbenzo[d][1,3]dioxole-4-carbaldehyde化学式
CAS
134817-17-7
化学式
C10H10O3
mdl
——
分子量
178.188
InChiKey
RMOKRPOMUJFXSE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Huang Ded-Shih, Ting Su-Hwa, J. Chem. Res. Synop, (1994) N 12, S 500-501
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Preparation of chiral cyanohydrins by an oxynitrilase-mediated transcyanation
    摘要:
    The transcyanation of aromatic and aliphatic aldehydes 1 (RCHO) with acetone cyanohydrin is catalyzed by the enzyme D-oxynitrilase to afford (R)-cyanohydrins 2 (RCH(OH)CN). The biocatalytic method using acetone cyanohydrin gives products of high enantiomeric purity with better consistency than similar conditions using hydrogen cyanide as the cyanide source. The use of an ether-buffer biphasic solvent system is essential for producing products of optimum optical purity, but the solubility properties of the substrate have a pronounced effect on the enantiomeric purity of the final product. A discussion relating the solubility partition coefficient (log P) of a substrate to the enantiomeric purity of the product as a guide for predicting the outcome with new substrates is presented. Application of the method to the preparation of the following cyanohydrins is reported (R, ee): a, C6H5, 92% ee; b, 3,4-(CH2O2)C6H3, 90% ee; c, 2-(CH3O)C6H4, 96% ee; d, C6H5CH2, 88% ee; e, CH3SCH2CH2, 92% ee; f, CH3(CH2)5CH2, 92% ee; g, (CH3)3C, 92% ee; h, c-C6H11, 96% ee; i, CH3O2C(CH2)6CH2, 97% ee; j, (E,E)-CH3CH = CHCH = CH, 96% ee; k, (CH3)2C = CHCH2CH2C(CH3) = CH, 99% ee.
    DOI:
    10.1021/ja00018a042
点击查看最新优质反应信息

文献信息

  • NOVEL DIAZASPIROALKANES AND THEIR USE FOR TREATMENT OF CCR8 MEDIATED DISEASES
    申请人:Borjesson Lena
    公开号:US20090156575A1
    公开(公告)日:2009-06-18
    The invention provides compounds of general formula wherein A, B, p, w, x, y, and z are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    本发明提供了一般式为的化合物,其中A、B、p、w、x、y和z的定义如规范中所述,以及其制备方法、包含它们的药物组合物和它们在治疗中的应用。
  • Increasing Selectivity of CC Chemokine Receptor 8 Antagonists by Engineering Nondesolvation Related Interactions with the Intended and Off-Target Binding Sites
    作者:Igor Shamovsky、Chris de Graaf、Lisa Alderin、Malena Bengtsson、Håkan Bladh、Lena Börjesson、Stephen Connolly、Hazel J. Dyke、Marco van den Heuvel、Henrik Johansson、Bo-Göran Josefsson、Anna Kristoffersson、Tero Linnanen、Annea Lisius、Roope Männikkö、Bo Nordén、Steve Price、Lena Ripa、Didier Rognan、Alexander Rosendahl、Marco Skrinjar、Klaus Urbahns
    DOI:10.1021/jm900713y
    日期:2009.12.10
    The metabolic stability and selectivity of a series of CCR8 antagonists against binding to the hERG ion channel and cytochrome Cyp2D6 are studied by principal component analysis. It is demonstrated that an efficient way of increasing metabolic stability and selectivity of this series is to decrease compound lipophilicity by engineering nondesolvation related attractive interactions with CCR8, as rationalized by three-dimensional receptor models. Although Such polar interactions led to increased compound selectivity, such a strategy could also jeopardize the DMPK profile of compounds. However, once increased potency is found, the lipophilicity can be readjusted by engineering hydrophobic substituents that fit to CCR8 but do not fit to hERG. Several such lipophilic fragments are identified by two-dimensional fragment-based QSAR analysis. Electrophysiological measurements and site-directed mutagenesis studies indicated that the repulsive interactions of these fragments with hERG are caused by steric hindrances with residue F656.
  • DING, Y. -S.;SHIUE, C. -Y.;FOWLER, J. S.;WOLF, A. P.;PLENEVAUX, A., J. FLUOR. CHEM., 48,(1990) N, C. 189-206
    作者:DING, Y. -S.、SHIUE, C. -Y.、FOWLER, J. S.、WOLF, A. P.、PLENEVAUX, A.
    DOI:——
    日期:——
  • Huang Ded-Shih, Ting Su-Hwa, J. Chem. Res. Synop, (1994) N 12, S 500-501
    作者:Huang Ded-Shih, Ting Su-Hwa
    DOI:——
    日期:——
  • US5840997A
    申请人:——
    公开号:US5840997A
    公开(公告)日:1998-11-24
查看更多

同类化合物

(5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) 黄樟素氧化物 黄樟素乙二醇; 2',3'-二氢-2',3'-二羟基黄樟素 黄樟素 风藤酰胺 非哌西特盐酸盐 非哌西特 盐酸盐 角秋水仙碱 螺[1,3-苯并二氧戊环-2,1'-环己烷]-5-胺 蓝细菌 苯并[d][1,3]二氧杂环戊烯-5-胺盐酸盐 苯并[d][1,3]二氧代l-5-甲基(2-氧代乙基)氨基甲酸叔丁酯 苯并[d][1,3]二氧代l-5-氨基甲酸叔丁酯 苯并[d][1,3]二氧代-4-甲腈 苯并[d][1,3]二氧代-4-氨基甲酸叔丁酯 苯并[d[1,3]二氧代-4-羧酰胺 苯并[1,3]二氧杂环戊烯-5-基甲基2-氯乙酸酯 苯并[1,3]二氧杂环戊烯-5-基甲基-苄基-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-[2-(4-氟-苯基)-乙基]-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(四氢-呋喃-2-基甲基)-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(2-氟-苄基)-胺 苯并[1,3]二氧杂环戊烯-5-基甲基-(1-甲基-哌啶-4-基)-胺 苯并[1,3]二氧代l-5-甲基-吡啶-3-甲基-胺 苯并[1,3]二氧代l-5-甲基-(4-氟-苄基)-胺 苯并[1,3]二氧代l-5-乙酸甲酯 苯并[1,3]二氧代-5-羧酰胺盐酸盐 苯并[1,3]二氧代-5-甲基肼盐酸盐 苯并[1,3]二氧代-5-甲基吡啶-4-甲胺 苯并[1,3]二氧代-5-甲基-吡啶-2-甲胺 苯并[1,3]二氧代-5-乙酰氯 苯并-1,3-二氧杂环戊烯-5-甲醇丙酸酯 苯乙酸,1-(1,3-苯并二氧杂环戊烯-5-基)-3-丁烯-1-基酯 苯乙酮O-((4-(3,4-亚甲二氧基苄基)-1-哌嗪-1-基)羰基甲基)肟 苯,1-甲氧基-6-硝基-3,4-亚甲二氧基- 芝麻酚 胡椒醛肟 胡椒醛,二苄基缩硫醛 胡椒醛 胡椒醇 胡椒酸酰氯 胡椒酸 胡椒腈 胡椒环乙酮肟 胡椒环 胡椒基重氮酮 胡椒基甲醛 胡椒基氯 胡椒基戊二烯酸钾 胡椒基丙醛 胡椒基丙酮